Chemically synthesized sugar-cholestanols possess a preferential anticancer activity involving promising therapeutic potential against human esophageal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17640296

Download in:

View as

General Info

PMID
17640296